Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7313 p246
21 August 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Warning over thyroid hormone treatment of pregnant women

Use of thyroid hormones in women with hypothyroidism who become pregnant has come under the spotlight following a study published last week (JAMA 2004;292:691).

Researchers have concluded that high levels of thyroid hormone in pregnant women can increase the risk of miscarriage or result in a lower birth weight for their infants. They came to their conclusions after investigating the effects of excess thyroid hormone among members of a family with mutations in the thyroid-hormone receptor gene. Affected people have a resistance to thyroid hormone and so compensate with increased thyroid gland activity. By comparing pregnancy outcomes in affected and unaffected members of the family, the researchers were able to show that high serum levels of thyroid hormone were associated with a higher rate of miscarriage. Furthermore, offspring who inherited the genetic mutation and so were resistant to the hormone had a higher birth weight than their unaffected siblings.

“Given the established importance of providing thyroid hormone to even mildly hypothyroid pregnant women, it is important to recognise that over-replacement appears to be equally detrimental,” they conclude.

Back to Top


©The Pharmaceutical Journal